Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Elbirt

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
AIDS (London, England)|June 23, 2026
Monthly oral pre-exposure prophylaxis and the importance of tissue pharmacokinetics: lessons from islatravirDaniel Elbirt, Andrew Hill
Rambam Maimonides Medical Journal|January 28, 2026
Response to Letter to the Editor: Prospective Validation of PaDd-A RoadmapRamon Cohen, Daniel Elbirt
AIDS (London, England)|June 27, 2024
Should we continue to use tenofovir disoproxil fumarate/lamivudine/dolutegravir for treatment of pregnant women? Interpreting the PROMISE trialAndrew M Hill, Daniel Elbirt
The Israel Medical Association Journal : IMAJ|November 18, 2008
Mother to child transmission of the human immunodeficiency virusZev M Sthoeger, Daniel Elbirt
Harefuah|May 18, 2011
[AIDS--2010]Zev Sthoeger, Ilan Asher, Daniel Elbirt
Harefuah|September 9, 2005
[Desloratadine for chronic idiopathic urticaria]Menachem Rottem, Daniel Elbirt, Zev Sthoeger, et al.
Harefuah|January 15, 2014
[Situations in which the primary care physician should suspect the presence of HIV-1 infection]Zev Sthoeger, Ilan Asher, Daniel Elbirt
The Israel Medical Association Journal : IMAJ|April 26, 2005
Cardiovascular disease prevention and treatment in patients with human immunodeficiency virusEli Magen, Daniel Elbirt, Zev Sthoeger
Harefuah|June 21, 2002
[Behçet's disease--clinical presentation, diagnostic and therapeutic approach]Daniel Elbirt, Ilan Asher, Zev M Sthoeger
Acta Neurologica Belgica|June 11, 2021
Incidence of acute ischemic cerebrovascular events in a cohort of HIV-infected patientsAnda Eilam, Volodymyr Samogalsky, Daniel Elbirt, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
AIDS (London, England)|June 23, 2026
Monthly oral pre-exposure prophylaxis and the importance of tissue pharmacokinetics: lessons from islatravirDaniel Elbirt, Andrew Hill
Rambam Maimonides Medical Journal|January 28, 2026
Response to Letter to the Editor: Prospective Validation of PaDd-A RoadmapRamon Cohen, Daniel Elbirt
AIDS (London, England)|June 27, 2024
Should we continue to use tenofovir disoproxil fumarate/lamivudine/dolutegravir for treatment of pregnant women? Interpreting the PROMISE trialAndrew M Hill, Daniel Elbirt
The Israel Medical Association Journal : IMAJ|November 18, 2008
Mother to child transmission of the human immunodeficiency virusZev M Sthoeger, Daniel Elbirt
Harefuah|May 18, 2011
[AIDS--2010]Zev Sthoeger, Ilan Asher, Daniel Elbirt
Harefuah|September 9, 2005
[Desloratadine for chronic idiopathic urticaria]Menachem Rottem, Daniel Elbirt, Zev Sthoeger, et al.
Harefuah|January 15, 2014
[Situations in which the primary care physician should suspect the presence of HIV-1 infection]Zev Sthoeger, Ilan Asher, Daniel Elbirt
The Israel Medical Association Journal : IMAJ|April 26, 2005
Cardiovascular disease prevention and treatment in patients with human immunodeficiency virusEli Magen, Daniel Elbirt, Zev Sthoeger
Harefuah|June 21, 2002
[Behçet's disease--clinical presentation, diagnostic and therapeutic approach]Daniel Elbirt, Ilan Asher, Zev M Sthoeger
Acta Neurologica Belgica|June 11, 2021
Incidence of acute ischemic cerebrovascular events in a cohort of HIV-infected patientsAnda Eilam, Volodymyr Samogalsky, Daniel Elbirt, et al.
Pageof 8